Trump Eases Psychedelic Restrictions

In a significant shift in federal drug policy, President Donald Trump signed an executive order aimed at fast-tracking research into psychedelics.

The order focuses on substances like ibogaine, which are currently banned under federal law but have gained support among conservative lawmakers and combat veterans.

During the signing ceremony, which included podcaster Joe Rogan, Trump joked about the drugs' effects while emphasizing their potential for mental health treatment.

The move aligns with a growing national momentum for psychedelic-assisted therapy to address the veterans' health crisis.